SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-043096
Filing Date
2014-06-23
Accepted
2014-06-23 16:08:33
Documents
1
Period of Report
2014-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4144
  Complete submission text file 0001209191-14-043096.txt   5538
Mailing Address TARGETED GENETICS CORP 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address
LACASSE LOUIS P (Reporting) CIK: 0001216489 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 14935271

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations